Cell-Based Assays

Cell-based assays are essential for the drug development process. Compared to biochemical assays, cell-based assays provide more physiological relevance for drug testing in the context of a complete biological system. In addition, other components, such as cell toxicity and drug effects on multiple cellular targets, can be assessed simultaneously. At NUVISAN, we provide precisely designed and validated cell-based assays for high-throughput screening and drug validation in later stages of the hit-to-lead and lead optimization processes.

Our cell-line platform operates with a wide range of cell systems. For standard cell-based assays, we provide off-the-shelf reporter cell lines to quick-start your assay development campaign. More complex assays can also be addressed directly in both primary cells and iPSCs. Explore more: Cell-line platform

Our state-of-the-art infrastructure supports the development of classical end-point assays, kinetic readouts in living cells, and high-throughput imaging assays (HCA). Explore more: Assay systems

In later stages of the lead discovery phase, it is often necessary to apply advanced assay strategies to better characterize the mode of action. Here, we can also help to find the right solution. Explore more: Advanced assays